1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gómez-Bernal F, Quevedo Abeledo JC, Almeida-Santiago C, Fernández-Cladera Y, García-Barrera E, Villar LM, Largo R, Ocejo-Vinyals JG, González-Gay MÁ, Ferraz-Amaro I.

    Clinical and serological associations of interferon-a and interferon-? in rheumatoid arthritis patients.

    RHEUMATOLOGY . 65(2): .

    [doi:10.1093/rheumatology/keag036]

  • Comabella M, Gutierrez L, Castillo M, Villar LM, Eixarch H, La Puma D, Aroca M, Vilaseca A, Montalban X, Fissolo N.

    Impact of preanalytical factors on blood CHI3L1 levels.

    Frontiers in immunology . 16: 1720914-1720914.

    [doi:10.3389/fimmu.2025.1720914]

  • Fissolo N, Benkert P, Vilaseca-Jolonch A, Blanco Y, Hegen H, Berek K, Pérez-Miralles F, Rejdak K, Villar L, Monreal E, Alvarez-Lafuente R, Bachhuber F, Tumani H, Martínez-Yelamos S, Sánchez-López A, García-Merino A, Gutiérrez L, Castillo-Triviño T, Lycke J, Rosenstein I, Téllez N, Furlan R, Lünemann JD, Khalil M, Kuhle J, Montalban X, Comabella M.

    Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

    EUROPEAN JOURNAL OF NEUROLOGY . 33(2): .

    [doi:10.1111/ene.70480]

  • Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A.

    XVII Reunión Post-ECTRIMS: Revisión de las Novedades Presentadas en el Congreso ECTRIMS 2024 (Parte II).

    REVISTA DE NEUROLOGIA . 81(1): 39228-39228.

    [doi:10.31083/RN39228]

  • Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A.

    XVII Reunión Post-ECTRIMS: Revisión de las Novedades Presentadas en el Congreso ECTRIMS 2024 (Parte I).

    REVISTA DE NEUROLOGIA . 81(1): 39227-39227.

    [doi:10.31083/RN39227]

  • García de la Torre I, García-Hoz C, Martin-Moro F, Fernández-Velasco JI, Velázquez-Kennedy K, Rodríguez-Martín E, Luna De Abia A, Roldán E, Moreno Jiménez G, López-Jiménez J, Villar LM, Pariente-Rodríguez R.

    Apheresis CD8(+)CCR7(+)CD45RA(-) T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(2): .

    [doi:10.3390/ijms27020866]

  • Martín-Pedraza L, Rodríguez-Martín E, De La Torre-Tarazona E, Moreno E, Pariente-Rodríguez R, Walo-Delgado PE, García-Pérez J, Díaz J, Luna L, Rodríguez-Dominguez M, Galán JC, Geraldine Rita C, Del Amo-de Palacios A, Navarro-Soler R, Fons M, Alcamí J, Moreno S, Villar LM, Serrano-Villar S.

    Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics.

    Frontiers in immunology . 16: 1693903-1693903.

    [doi:10.3389/fimmu.2025.1693903]

  • Domínguez-Ruiz M, Chico JL, López-Marín L, Stanescu S, Crujeiras P, Rodrigues D, Heras-Alonso ML, Torremocha R, Meijón-Ortigueira MDM, Muñoz-Díez P, Lanza VF, Colón C, Villarrubia J, Belanger A, Castillo FJD.

    Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease

    Biomedicines . 13(12): .

    [doi:10.3390/biomedicines13123114]

  • Landete L, Gómez-Ballesteros R, Meca-Lallana V, Caminero AB, Meca-Lallana JE, Martínez-Yélamos S, García-Domínguez JM, Agüera E, García-Arcelay E, Medrano N, Villar LM, Monreal E, Maurino J.

    How do neurologists perceive the organization and functioning of multiple sclerosis care units?

    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 11(4): .

    [doi:10.1177/20552173251406791]

  • Rodero-Romero A, Domínguez-Mozo M, Monreal E, García-Domínguez JM, Villarrubia N, Fernández-Velasco JI, Comabella M, de la Maza SS, Goicochea Briceño H, Chico-García JL, García-Martínez MÁ, Rodriguez-Jorge F, Veiga-Gonzalez JL, Sainz-Amo R, Martínez Ginés ML, Montalban X, Masjuan J, Costa-Frossard L, Álvarez-Lafuente R, Villar LM.

    New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

    Frontiers in immunology . 16: 1729500-1729500.

    [doi:10.3389/fimmu.2025.1729500]

  • González-Gay MÁ, Gómez-Bernal F, Quevedo-Abeledo JC, Almeida-Santiago C, Heras-Recuero E, Torres-Roselló A, de Vera-González A, Tejera-Segura B, García-Barrera E, Blázquez-Sánchez T, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.

    Ultrasensitive quantification of serum IFN-a and IFN-? in systemic lupus erythematosus: A cross-sectional observational study

    PLOS MEDICINE . 22(12): .

    [doi:10.1371/journal.pmed.1004841]

  • González-Gay MÁ, Gómez-Bernal F, Heras-Recuero E, Quevedo-Abeledo JC, De Vera-González A, Tejera-Segura B, Gómez-Moreno C, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.

    Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus.

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . : .

    [doi:10.55563/clinexprheumatol/jgz1oz]

  • Keller CW, Stein K, Vilaseca A, Villar LM, Álvarez-Bravo G, Protopapa M, Shin J, Fissolo N, Martínez-Rodríguez JE, Quiroga-Varela A, García-Sarreón A, Gutiérrez L, Midaglia L, Montalban X, Lünemann JD, Comabella M.

    Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome

    Frontiers in immunology . 16: 1680233-1680233.

    [doi:10.3389/fimmu.2025.1680233]

  • Muñoz-Reyes D, Aguado L, Arroyo-Urea S, Requena C, Pérez-Suárez S, Sánchez-Yepes S, Argerich J, Miró-Rodríguez C, Ulzurrun E, Rodríguez-Martín E, García-Nafría J, Campillo NE, Mansilla A, Sánchez-Barrena MJ.

    FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction

    JOURNAL OF MEDICINAL CHEMISTRY . 68(22): 23993-24010.

    [doi:10.1021/acs.jmedchem.5c01626]

  • Torres Iglesias G, Chavarría-Miranda A, López-Molina M, Del Fresno C, Mata-Martínez P, Nozal P, Chico-Garcia JL, Fernández-Fournier M, Lacruz Ballester L, Sanchez D, Montero-Calle A, Barderas R, Bravo S, Puertas I, York E, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L.

    Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 12(6): .

    [doi:10.1212/NXI.0000000000200483]

  • El Mahdaoui S, Kosa P, Komori M, Veiga González JL, Chow HH, Ratzer R, Madsen CG, Siebner HR, Bielekova B, Villar LM, Romme Christensen J, Sellebjerg F.

    Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands

    JOURNAL OF NEUROIMMUNE PHARMACOLOGY . 20(1): 98-98. Nº de citas: 1

    [doi:10.1007/s11481-025-10263-w]

  • Rodero-Romero A, Fernández-Velasco JI, Monreal E, Sainz-Amo R, Álvarez-Lafuente R, Comabella M, Ramió-Torrentà L, García-Domínguez JM, Villarrubia N, Sainz de la Maza S, Domínguez-Mozo M, Quiroga-Varela A, Chico-García JL, Rodriguez-Jorge F, Veiga-Gonzalez JL, Roldán-Santiago E, Espiño M, Rodríguez-Martín E, Álvarez G, Masjuan J, Montalban X, Costa-Frossard L, Villar LM.

    Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

    Frontiers in immunology . 16: 1648725-1648725. Nº de citas: 1

    [doi:10.3389/fimmu.2025.1648725]

  • Gajate Martín L, de la Hoz I, Martín M, Fernández C, Martín Grande A, Parise D, Villahoz J, Gómez M, Espiño M, Pastor O, Rodríguez Gandía MÁ, Nuño J.

    A randomized trial of ascorbic acid for the prevention of post-reperfusion syndrome during liver transplantation

    Hepatology Communications . 9(8): . Nº de citas: 2

    [doi:10.1097/HC9.0000000000000777]